DATAPHARM A/S: Financial statements 2013
CVR: 72323211
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
DATAPHARM A/S (CVR 72323211) has filed annual accounts for 2013. In 2013, the company reported a net result of DKK 360,567 compared with DKK -519,175 the year before. Equity in the 2013 report amounted to DKK 7,081,407. The solvency ratio was 66.5%.
- Profit/Loss
- DKK 360,567
- Equity
- DKK 7,081,407
- Total Assets
- DKK 10,644,557
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | - | 361 t. | 7.1 mio. | - |
| 2012 | 1.6 mio. | -584 t. | -519 t. | 6.7 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
DATAPHARM A/S has published its annual report for 2012. Revenue came to DKK 1,633,566, and the net result was DKK -519,175.
As of April 23, 2013, Helle Steen Sørensen has joined the board of directors of DATAPHARM A/S.
As of April 23, 2013, Steen Mejlgaard has left the board of directors of DATAPHARM A/S.
About DATAPHARM A/S
DATAPHARM A/S is a Danish company of the type Aktieselskab based in København K, founded in 1983. The company is registered under the industry Computerprogrammering. The management consists of Henrik Bruun. The board consists of Dan Asmussen (chair), Dorte Kamp Teglgård, Jonas Arendal Grønskov and Mia Bendix Andersen. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 4 employees (2004). In 2025, the company reported a net result of DKK 657,407 compared with DKK 650,613 the year before. Equity in the 2025 report amounted to DKK 11,750,274.